Phase
Condition
Glaucoma
Vascular Diseases
Circulation Disorders
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Documented diagnosis of ocular hypertension with an open angle of Schaffer Grade 3 orgreater or open-angle glaucoma without pseudoexfoliation or pigment dispersion orevidence of traumatic angle recession
- IOP is currently controlled as assessed by the Investigator
Exclusion
Exclusion Criteria:
- Punctum size smaller than 0.4 mm or greater than 0.9 mm in either eye as measuredusing a standard punctum gauge
- A history of an inadequate response or no response to topical prostaglandin
- Known or suspected allergy and/or hypersensitivity to travoprost or any prostaglandin,fluorescein, or to any component of the study products
Study Design
Study Description
Connect with a study center
Artesia, California
United StatesSite Not Available
Colorado Springs, Colorado
United StatesSite Not Available
Lakeland, Florida
United StatesSite Not Available
Morrow, Georgia
United StatesSite Not Available
empty
Shawnee, Kansas
United StatesSite Not Available
Shawnee Mission, Kansas
United StatesSite Not Available
Des Peres, Missouri
United StatesSite Not Available
Fichte, Endl & Elmer Eyecare
Amherst, New York 14228
United StatesSite Not Available
Rochester, New York
United StatesSite Not Available
Raleigh, North Carolina
United StatesSite Not Available
Cincinnati, Ohio
United StatesSite Not Available
Austin, Texas
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.